Medication-related emergency department visits and hospitalizations among older adults

Canadian Family Physician

Volumn 60, Issue 4, 2014, Pages

  Bayoumi, Imaan ^a   Dolovich, Lisa ^a   Hutchison, Brian ^a   Holbrook, Anne ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENOL; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; CONTRAST MEDIUM; CORONARY VASODILATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; INSULIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; PROTON PUMP INHIBITOR; DRUG;

AGED; ARTICLE; CANADA; CROSS-SECTIONAL STUDY; EMERGENCY CARE; EMERGENCY WARD; GENERAL PRACTITIONER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; SIDE EFFECT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY HEALTH SERVICE; FACTUAL DATABASE; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY SERVICE, HOSPITAL; HOSPITALIZATION; HUMANS; ONTARIO; PHARMACEUTICAL PREPARATIONS; PRIMARY HEALTH CARE;

EID: 84925545944     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995;274(1):29-34.
2. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002;36(7-8):1238-48.
3. Handler SM, Wright RM, Ruby CM, Hanlon JT. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006;4(3):264-72.
4. Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45(7-8):977-89. Epub 2011 Jun. 21.
5. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365(21):2002-12.
6. Canadian Institute for Health Information. Data quality documentation, Discharge Abstract Database 2007-2008. Executive summary. Ottawa, ON: Canadian Institute for Health Information; 2009. Available from: www.cihi.ca/CIHI-ext- portal/pdf/internet/PDF-DAD-EXECSUM-08-09-EN. Accessed 2014 Mar. 13.
7. Canadian Institute for Health Information. Database background and general data limitations documentation, National Ambulatory Care Reporting System, 2008-2009. Executive summary. Ottawa, ON: Canadian Institute of Health Information; 2008. Available from: www.cihi.ca/CIHI-ext-portal/pdf/internet/ NACRS-EXEC-SUMM-2007-2008-EN. Accessed 2014 Mar. 13.
8. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011;171(11):1013-9.
9. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296(15):1858-66.
10. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280(15):1311-6.
11. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993;8(6):289-94.
12. Bates DW, Teich JM, Lee J, Seger DL, Kuperman GJ, Ma'Luf N, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999;6(4):313-21.
13. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109(2):87-94.
14. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289(9):1107-16.
15. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs and attributable mortality. JAMA 1997;277(4):301-6.
16. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005;118(3):251-8.
17. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348(16):1556-64.
18. Hougland P, Xu W, Pickard S, Masheter C, Williams S. Performance of International Classification of Diseases, 9th revision, clinical modification codes as an adverse event surveillance system. Med Care 2006;44(7):629-36.
19. Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178(12):1563-9.w